Explore more about: Biomaterials

Engineers have developed a light-sensitive material that allows gastrointestinal devices to be triggered to break down inside the body when they are exposed to light from an ingestible LED.

Millions of people are treated with antibiotics each year for infections or as a preventative measure. Two teams of NIBIB-funded scientists have been working to find alternative solutions for treating bacterial infections, especially antibiotic-resistant bacteria.

What factors affect how human touch perceives softness, like the feel of pressing your fingertip against a marshmallow, a piece of clay or a rubber ball? By exploring this question in detail, researchers discovered clever tricks to design materials that replicate different levels of perceived softness. The findings provide fundamental insights into designing tactile materials and haptic interfaces that can recreate realistic touch sensations.

The development of new bone can be a multistep process: first, stem cells differentiate into cartilage cells. Next, the cartilage cells become bone cells. But that's not all: the cells must experience some mechanical stresses during the transformation in order to transform efficiently from stem cells to bone cells.

Bioengineers used bone engineered in a 3D-printed mold and grown alongside the ribs of sheep to successfully replace a portion of the animals’ jaw bones.

Researchers have created 3D printed customized implants that may boost the power of cell-based therapies for repairing injured spinal cords.

Bioengineers have developed a 3D printing technique that creates the interacting networks for transport of air, blood, and other bodily fluids—a major step toward 3D printed replacement organs.

NIBIB-funded researchers have designed a new class of 2D nanomaterials that are disc-shaped and flat on the surface, to aid in treatments for cartilage repair.

Researchers funded by NIBIB have designed neuron-like probes that can be implanted and remain viable for long-term use to study and treat the brain.

An NIH-funded team at the University of Colorado (UC) has assembled a clearer picture of the molecular activity that occurs when nanoparticles injected into the body are marked for immune system attack.